Abbott Laboratories is adding HPV screening to its "Alinity m" family of diagnostic assays following U.S. Food & Drug Administration approval. Abbott said in a press release that the FDA approved its ...
Abbott Laboratories, Inc. ABT recently announced the receipt of the FDA approval for the Alinity i laboratory traumatic brain injury (TBI) blood test. This will be the first commercially available TBI ...
-- Abbott's Alinity™ m Resp-4-Plex assay will allow healthcare workers to test for four viruses in one test, a critically important tool as flu presents with similar symptoms -- The test helps save on ...
According to the U.S. Centers for Disease Control (CDC), most sexually active adults will experience HPV infections; new test detects those HPV genotypes that could lead to cancer Abbott (ABT)'s new ...
Abbott has recalled two of its Alinity COVID-19 test kits after finding they can yield false positive results. Abbott is recalling its Alinity m SARS-CoV-2 AMP kit and Alinity m Resp-4-Plex AMP kit, ...
The FDA urged clinical laboratories and healthcare providers to retest any patients who have recently received a positive result from two of Abbott’s PCR COVID-19 assays after identifying a heightened ...
The test measures glial fibrillary acidic protein and ubiquitin carboxyl-terminal hydrolase L1, biomarkers present in blood plasma at elevated concentrations after a brain injury. The Food and Drug ...
CT scan of a brain of a patient with subdural hemorrhage, interhemispheric hemorrhage and cerebral edema from trauamatic brain injury (TBI). (CT scan of a brain of a patient with subdural hemorrhage, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback